Processa Pharmaceuticals Inc expected to post a loss of 77 cents a share - Earnings Preview

Processa Pharmaceuticals

06/05/2025 22:32

Processa Pharmaceuticals Inc PCSA.OQ PCSA.O is expected to report results on May 8 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Processa Pharmaceuticals Inc is for a loss of 77 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Processa Pharmaceuticals Inc is $6.00​, above​ its last closing price of $0.25. ​​​

This summary was machine generated May 6 at 21:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)